EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Select your location
Local sites
Life Sciences industry
Unleash holistic innovation for improved health outcomes and shareholder value.
The life sciences industry faces increasing pressure to offer healthy returns to its investors by innovating new therapies. How do you build operational resilience and keep innovating in an increasingly complex landscape?
We can help you unleash the enterprise-wide power using the incisive strategy, functional expertise and scale.
We work with you to anticipate trends and bring perspectives to enable business strategy with technology and help your financial resiliency in a tax-efficient model. We can assist your growth strategy, both organically and through smart acquisitions. We can help improve your capital deployment toward better shareholder returns, so you can do what you do best: discover, develop and commercialize the most innovative therapies, devices and treatment modalities.
Our latest thinking on the Life Sciences industry
The future state of transfer pricing controversy for life sciences
In this webcast, panelists discuss global transfer pricing controversy matters for life sciences companies. Register now.
05 Mar 2025 | your local time
How biopharma can get the right mix of people and tech for launch success
Facing a challenging commercial environment, biopharma companies need to embrace an end-to-end, AI-driven strategy to succeed. Read more.
04 Mar 2025
Daniel Mathews
Beyond integration: Value creation from bolt-on life sciences deals
Discover strategies for successful bolt-on acquisitions in life sciences for 2025. Read the full article for essential insights.
03 Mar 2025
Ranu Carroll
How to navigate the immigration landscape in the Trump administration
In this webcast, panelists discuss the impact of recent executive actions related to immigration issues and policy in the US. Learn more.
25 Feb 2025 | your local time
How AI can support decision-making in drug development portfolios
AI can be a powerful tool in the pharmaceutical industry to drive decision-making in drug development portfolios. Learn more.
20 Feb 2025
Benoit Millet
How real-time release (RTR) can transform pharmaceutical manufacturing
Real-time release has significant potential in pharmaceutical manufacturing, but companies hoping to adopt it must meet several prerequisites. Learn more.
19 Feb 2025
Srihari Rangarajan
AI funding kicks into overdrive in Q4 2024
Learn more about what entrepreneurs and investors are doing to navigate the current VC market.
22 Jan 2025
Jeffrey Grabow
EY Firepower report: life sciences dealmaking – trends in 2025
Learn how smaller, smarter deals will shape a confident future for life sciences.
13 Jan 2025
How an authentic journey brought leadership success
Johnson & Johnson executive Alyson Lawrence advises leading with authenticity and honesty. Read more.
10 Jan 2025
Juan Uro
Optimism for life sciences growth amid policy shifts in 2025
Discover how pharma companies are driving growth in 2025 through tech adoption and strategic deal making.
13 Dec 2024
Arda Ural, PhD
Transforming compliance with advanced strategies and technologies
Learn how multinationals are approaching compliance challenges and driving advancements. Read the 2024 Global Integrity Report – US edition.
19 Sep 2024
Liban Jama
How life sciences legal departments can create financial efficiency
Discover life sciences legal department strategies to boost efficiency and cut costs
18 Dec 2024
Kristi Gedid
Pulse on MedTech: How the industry is adapting to thrive
Current MedTech industry analysis on dealmaking, financing and commercial strategies, with insights on growth, AI, consumer and future state.
09 Dec 2024 | your local time
Election aftermath: implications for life sciences companies
Join our webcast to explore the 2024 election’s impact on life sciences with insights on drug prices, supply chain and more. Register now!
06 Dec 2024 | your local time
How one health care testing company gets results with AI
By leveraging AI and automation, patient diagnostics have picked up pace in a health care testing company. Learn more in this case study.
04 Dec 2024
Ricardo Vilanova
EY webcast: Shaping the future of health equity
In this webcast, panelists discuss findings from the EY Health Equity Outlook Report, exploring the evolution and future of health equity practices.
19 Nov 2024 | your local time
How life sciences CIOs can make the most of GenAI investments
Optimism about GenAI is spreading among CIOs of life sciences organizations, which must focus on key priorities to benefit from the technology. Read more.
11 Nov 2024
Ricardo Vilanova
Pulse of the MedTech Industry report 2024
2024 EY MedTech report on dealmaking, financing, and state of the industry, with insights on growth and commercial strategies, AI, consumer and more.
07 Oct 2024
Jim Welch
How Bayer is unearthing agronomy's future with generative AI
Read this case study to learn how Bayer Crop Science is using large language models to plant the seeds of the future.
16 Sep 2024
Beyond Borders: EY Biotechnology Report 2024
New EY biotechnology report with deal, financing and other data, plus insights on AI, GLP-1 drugs, oncology breakthroughs, the VC lens and much more.
03 Jun 2024
Case study: Accelerated clinical trial activation at UCSD MCC
This case study shows how Moores Cancer Center implemented EY Clinical Trial Fast Lane to accelerate trial activation and access to novel therapies
31 May 2024
Salman Shah
How strategic partnerships can benefit life sciences companies
Understanding and addressing the VAT and customs aspects of strategic partnerships are essential. Learn more.
15 Dec 2023
Minde King
How pharma can benefit from using GenAI in drug discovery
Using GenAI in drug discovery is a hot topic in the pharmaceutical industry, with speed and cost savings seen as potential benefits. Learn more.
29 Jan 2024
Ranu Carroll
How ecosystems transform customer journeys
Discover how an EY-orchestrated ecosystem can help companies create differentiated customer journeys.
22 Jan 2024
Scott Wellwood
How life sciences can make the right deals in a time of change
Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value? Learn more.
08 Jan 2024
Subin Baral
How generative AI can optimize health care supply chains
Technology lets organizations capture efficiencies and improve patient care. Find out more.
15 Dec 2023
Ryan Siemers
How tech and trust transformed a tax operating model
Global pharmaceutical player Boehringer Ingelheim is reimaging its tax operating model to boost quality and efficiency. Learn more in this case study.
30 May 2023
Why supply chain cost reduction has become a boardroom discussion
A multitude of challenges are reshaping the way COOs think about their supply chains, with cost transformation and resiliency leading the way. Learn more.
21 Nov 2024
Regenia Sanders
Why digital supply chain visibility should be a pharma priority
With digitally driven end-to-end supply chain visibility, pharma companies will be better prepared for the next major supply chain disruption. Learn more.
04 Oct 2023
Derron Stark
Redesigning operating models to drive life sciences excellence
Life sciences leaders face an evolving market landscape. Our operating model insights drive agility and resiliency. Read more.
08 Sep 2023
Qasim Zaidi
How digital is changing the tax strategy for MedTech
As MedTech companies make substantial investments in digital technology, there are important tax implications that should be addressed. Learn more.
18 Aug 2023
Ana Maria Romero
5 steps life sciences companies can take now to build resiliency
Life sciences executives focus on cost containment and agility in the face of economic and legislative challenges. Learn more.
07 Aug 2023
Kyle Braden
How Bayer became a preferred partner of clinical trial sites globally
For pharma, becoming a preferred clinical trial partner is all about leveraging tech to drive efficiencies and improve site relationships. Read more.
16 May 2023
Salman Shah
How a life sciences leader accelerated its DEI journey
Leading DEI strategies for biopharmas that boost productivity, governance and talent retention. Read more.
05 Dec 2023
Mary Augustine-Morris
2024 Health Equity Outlook Report
See how much progress has been made toward advancing health equity and read insights on trends and challenges in the 2024 EY Health Equity Outlook Report.
06 Mar 2024
What pharma supply chain transformation means for tax
Businesses looking to create visibility and resilience in their supply chains must loop in tax and transfer pricing teams early in the process. Learn more.
15 Mar 2024
Ana Maria Romero
Drive commercial success by effectively navigating loss of exclusivity
Pharmaceutical companies facing patent expiration must carefully craft the right brand strategy to increase value. Learn more.
09 Feb 2024
Qasim Zaidi
How digital helps pharma manufacturers drive operational excellence
Transform your pharma manufacturing operations with a digital-first approach
15 Dec 2022
Srihari Rangarajan
Key steps for improving biopharma expansion into new markets
As biopharma companies look to new markets for needed growth, leaders need to tailor the expansion approach to the nuances of each market. Learn more.
03 Jun 2024
Ranu Carroll
What if your people were the unrealized answer to value creation?
Boost M&A success in life sciences by safeguarding and prioritizing key leaders and employees.
31 Oct 2023
Shari Yocum
EY leaders in the Life Sciences industry
Direct to your inbox
Stay up to date with our Editor's picks newsletter.